TG Therapeutics, Inc. (NASDAQ:TGTX)

CAPS Rating: 5 out of 5

Caps

How do you think TGTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

61 Outperform
1 Underperform
 

All-Star Players

16 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top TGTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.73)
Submitted February 13, 2015

TG Therapeutics has been a popular topic on biotwitter for a couple of years, but I never had the time to put the stock into my database so I wasn't around for the monster move from 5 to 18 last year. Would I have taken the plunge and started a real… More

OklaBoston (58.63)
Submitted August 25, 2015

Only a matter of time before this loses at least 1 Star. AT LEAST 1!

TGTX VS S&P 500 (SPY)

Fools bullish on TGTX are also bullish on:

Fools bearish on TGTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about TGTX.

Recs

0
Member Avatar TMFang4apples (48.89) Submitted: 4/18/2018 1:32:21 PM : Outperform Start Price: $14.23 TGTX Score: -4.26

Can't understand how ublituximab's could be worth less than $1.1 billion on a risk-adjusted basis right now.

Recs

0
Member Avatar TurksFan (51.26) Submitted: 4/7/2018 8:43:26 AM : Outperform Start Price: $13.20 TGTX Score: -0.42

Starting my research into biotechs

Recs

0
Member Avatar TMFEBCapital (84.10) Submitted: 4/30/2017 1:16:33 PM : Outperform Start Price: $11.00 TGTX Score: +10.47

While it's anyone's guess if the FDA will require a second trial to confirm TG-1101s efficacy alongside Imbruvica in CLL before approving it, upcoming presentations in June at ASCO could help boost this company's shares over the coming month. After the conference, investors should have more info to digest on safety that could inform the chances of this drug getting across the regulatory finishline.

Leaderboard

Find the members with the highest scoring picks in TGTX.

Score Leader

thiscoloradokid

thiscoloradokid (< 20) Score: +249.47

TGTX has been a flat line on a weekly chart for over 2 years. It's now attracting significant accumulation. A very low relative price, long base, and increasing volume is very attractive.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
thiscoloradokid < 20 11/14/2013 Outperform 3M $3.42 +302.05% +52.58% +249.47 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Baseballmom1123 24.74 11/20/2013 Outperform 3Y $3.49 +293.98% +53.18% +240.80 0 Comment
Playa14 < 20 1/17/2017 Outperform 5Y $4.95 +177.78% +20.79% +156.99 0 Comment
StockElections 29.14 5/15/2014 Outperform 5Y $4.69 +193.18% +46.30% +146.88 0 Comment
TerryFool 24.56 4/15/2014 Outperform 5Y $5.00 +175.00% +50.10% +124.90 1 Comment
TerryHoodSr 54.08 4/15/2014 Outperform 5Y $5.26 +161.41% +49.28% +112.13 1 Comment
portefeuille 98.91 8/12/2016 Outperform 5Y $6.00 +129.17% +25.15% +104.02 0 Comment
portefeuille3 97.88 4/11/2014 Outperform 5Y $5.42 +153.69% +50.56% +103.13 0 Comment
lgrunner34 41.75 6/24/2016 Outperform 5Y $6.10 +125.41% +33.55% +91.86 0 Comment
jeepdrew222 89.44 9/8/2016 Outperform 5Y $6.70 +105.22% +25.04% +80.19 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.37 1/6/2015 Outperform 3W $15.70 -12.42% +36.80% -49.22 0 Comment

Featured Broker Partners